GHCM Stock Overview
Garofalo Health Care S.p.A. operates healthcare clinics in Italy.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 2/6 |
Past Performance | 5/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Garofalo Health Care S.p.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €4.35 |
52 Week High | €4.98 |
52 Week Low | €4.35 |
Beta | 0.70 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | -2.79% |
5 Year Change | n/a |
Change since IPO | -2.79% |
Recent News & Updates
Recent updates
Shareholder Returns
GHCM | GB Healthcare | GB Market | |
---|---|---|---|
7D | 0% | 0.4% | 0.7% |
1Y | n/a | -26.9% | -0.3% |
Return vs Industry: Insufficient data to determine how GHCM performed against the UK Healthcare industry.
Return vs Market: Insufficient data to determine how GHCM performed against the UK Market.
Price Volatility
GHCM volatility | |
---|---|
GHCM Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 7.1% |
Market Average Movement | 4.9% |
10% most volatile stocks in GB Market | 11.4% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: GHCM has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine GHCM's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 1,862 | Maria Garofalo | www.garofalohealthcare.com |
Garofalo Health Care S.p.A. operates healthcare centers in Italy. It offers services in the areas of high-complexity surgery, medium- and low-complexity surgery, emergency surgery, medicine, clinical and interventional cardiology, and extended and intensive care units, as well as motor, neurological, cardiac, and nutritional rehabilitation. The company also operates centers for patients in coma and persistent vegetative states; and psychiatric and diagnostic centers.
Garofalo Health Care S.p.A. Fundamentals Summary
GHCM fundamental statistics | |
---|---|
Market cap | €347.58m |
Earnings (TTM) | €19.60m |
Revenue (TTM) | €301.60m |
17.7x
P/E Ratio1.2x
P/S RatioIs GHCM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
GHCM income statement (TTM) | |
---|---|
Revenue | €301.60m |
Cost of Revenue | €233.99m |
Gross Profit | €67.61m |
Other Expenses | €48.01m |
Earnings | €19.60m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 0.22 |
Gross Margin | 22.42% |
Net Profit Margin | 6.50% |
Debt/Equity Ratio | 57.7% |
How did GHCM perform over the long term?
See historical performance and comparison